Loading clinical trials...
Loading clinical trials...
The aim of the study is to establish if caffeine consumption is associated with the evolution of the disease in premanifest HD.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Lille
NCT06826612 · Huntington Disease
NCT07451613 · Huntington Disease
NCT07253038 · Huntington Disease
NCT04012411 · Huntington Disease
NCT05326451 · Huntington Disease
CHU de Amiens
Amiens
CHU de Angers
Angers
CHU Pellegrin
Bordeaux
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions